Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of F5, Inc. (“F5” or the “Company”).

On October 15, 2025, F5 reported that “[o]n August 9, 2025, F5 . . . learned that a highly sophisticated nation-state threat actor had gained unauthorized access to certain Company systems.”

F5 also reported that “[d]uring the course of its investigation, the Company determined that the threat actor maintained long-term, persistent access to certain F5 systems, including the BIG-IP product development environment and engineering knowledge management platform. Through this access, certain files were exfiltrated, some of which contained certain portions of the Company’s BIG-IP source code and information about undisclosed vulnerabilities that it was working on in BIG-IP.”

On this news, the price of F5’s stock fell over 10%, from a close of $330.75 on October 15, 2025, to close at $295.35 on October 16, 2025. 

F5 Investors May Have Legal Claims

F5 investors with financial losses are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact John Kehoe, Esq., (215) 792-6676, Ext. 801, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.  

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Organon & Co. (“Organon”) (NYSE: OGN).

On October 27, 2025, Organon announced that “[o]n October 26, 2025, Kevin Ali resigned as Chief Executive Officer of Organon & Co. . . . and as a member of the Company’s Board of Directors . . ..”

The CEO resigned in connection with an internal investigation into Organon’s wholesaler sales practices.

On this news, Organon’s stock price was down more than 20% during intraday trading on October 27, 2025.

Organon Investors May Have Legal Claims

Investors of Organon stock with financial losses are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.  

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Intellia Therapeutics, Inc. (“Intellia” or the “Company”) (NASDAQ: NTLA).

On October 27, 2025, Intellia reported that “. . . it has temporarily paused dosing and screening in the MAGNITUDE and MAGNITUDE-2 Phase 3 clinical trials for nexiguran ziclumeran (‘nex-z’).”

Intellia stated that “[t]his action follows a report on October 24, 2025 of Grade 4 liver transaminases and increased total bilirubin in a patient who was dosed with nex-z in the MAGNITUDE trial on September 30, 2025, meeting the trial’s protocol-defined pausing criteria.”

On this news, Intellia’s stock price dropped more than 45% in pre-market trading on October 27, 2025.

On October 29, 2025, Intellia reported that the “. . . verbally informed the Company that the FDA has placed a clinical hold on the Investigational New Drug applications for the MAGNITUDE and MAGNITUDE-2 Phase 3 clinical trials for nexiguran ziclumeran (“nex-z”). FDA indicated that it would provide a formal Clinical Hold Letter within 30 calendar days.”

Intellia also reported that the “. . . clinical hold follows the previously disclosed report of Grade 4 liver transaminases and increased total bilirubin in a patient who was dosed with nex-z in the MAGNITUDE trial. As previously announced on October 27, 2025, the Company had temporarily paused dosing and screening in the MAGNITUDE and MAGNITUDE-2 Phase 3 clinical trials for nex-z based on the MAGNITUDE trial’s protocol-defined pausing criteria.”

On this news after the market closed on October 29, 2025, Intellia’s stock price was down more than 16%.

Intellia Investors May Have Legal Claims

Investors of Intellia stock with financial losses are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.  

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Jefferies Financial Group Inc. (“Jefferies” or “Jefferies Financial”) (NYSE: JEF).

The securities fraud investigation concerns whether Jefferies Financial or Point Bonita made materially false and misleading statements to investors regarding its $715 million in exposure to receivables of First Brands.

Jefferies stock dropped to $54.44 per share, down approximately 8%, on the news of Jefferies Financial’s exposure to Point Bonita’s trade finance portfolio.

Jefferies Investors May Have Legal Claims

Jefferies Financial investors are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact John Kehoe, Esq., (215) 792-6676, Ext. 801, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.  

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of WideOpenWest, Inc. (“WideOpenWest”) (NYSE: WOW).

The investigation concerns whether WideOpenWest’s entry into a definitive go-private agreement is in the best interests of shareholders.  

Under the proposed agreement, affiliated investment funds of DigitalBridge Investments, LLC and Crestview Partners (“Crestview”) will acquire all the outstanding shares of common stock of WideOpenWest not already owned by Crestview and its affiliates for $5.20 per share in an all-cash transaction.

WideOpenWest Investors May Have Legal Claims

WideOpenWest investors are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.  

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of MoonLake Immunotherapeutics (“MoonLake”) (NASDAQ: MLTX).

The investigation concerns MoonLake’s report “on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody® sonelokimab.” Among other things, MoonLake stated “[t]he higher-than-expected placebo response rate in VELA-2 is disappointing . . ..”

On the news of disappointing Phase 3 VELA results, MoonLake’s stock price dropped significantly and was down more than 89% during intraday trading on September 29, 2025.

Class Action Lawsuit Filed on Behalf of MoonLake Investors

On October 15, 2025, a class action complaint alleging violations of federal securities laws was filed against MoonLake on behalf of investors who purchased or otherwise acquired MoonLake common stock between March 10, 2024 and September 29, 2025, both dates inclusive (the “Class Period”). 

To view the class action complaint, click MoonLake Immunotherapeutics Class Action Complaint.

MoonLake Investors May Have Legal Claims

Investors who acquired MoonLake securities during the Class Period are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.  

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]